Prediabetes pp 365-376 | Cite as

Prevention of Diabetes-Related Retinal Microangiopathy with Aldose Reductase Inhibitors

  • W. Gerald RobisonJr.
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 246)


One of the most significant breakthroughs in research on diabetes since the advent of insulin was the discovery, in animal models, that the polyol pathway involving aldose reductase is responsible for tissue complications similar to those occurring in diabetic patients (1). Under diabetic conditions polyol accumulates in cells from the activity of aldose reductase which would normally remain inactive. The accumulation of intracellular polyol and associated loss of myo-inositol somehow result in alternations in cell function and eventual cell death, though the mechanisms are not thoroughly understood and may vary from tissues to tissue.


Basement Membrane Diabetic Retinopathy Aldose Reductase Mural Cell Aldose Reductase Inhibitor 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kinoshita, J.H., 1986, Aldose reductase in the diabetic eye, XLIII Edward Jackson Memorial Lecture. Amer J Ophthamol 102: 685–692.Google Scholar
  2. 2.
    Engerman, R.L., Kern, T.S., 1986, Hyperglycemia as a cause of diabetic retinopathy. Metabolism 35: 20–23.PubMedCrossRefGoogle Scholar
  3. 3.
    Robison, W.G., Jr., Nagata, M., 1988, Aldose reductase in mural cell loss and retinal capillary basement membrane thickening. Polyol Pathway and Its Role in Diabetic Complications. Sakamoto, N, Kinoshita, J.H., Kador, P.F. and Hotta, N., Eds. Amsterdam, Elsevier Science Publishers (Biomedical division): 267–275.Google Scholar
  4. 4.
    Timpl, R., Dziadek, M., 1986, Structure, development, and molecular pathology of basement membranes. International Rev Exp Pathol 29: 1–112.Google Scholar
  5. 5.
    McEwen, T.A.J., Chakrabarti, S., and Sima, A.A.F., 1987, A rapid reproducible method for determination of basement membrane thickness in biological structures. Comput Biol Med 17: 193–197.PubMedCrossRefGoogle Scholar
  6. 6.
    Cogan, D.G. and Kuwarbara, T., 1967, The mural cell in perspective. Arch Ophthalmol 78: 133–139.PubMedCrossRefGoogle Scholar
  7. 7.
    Akagi, Y., Terubayashi, H., Millen, J., Kador, P.F., Kinoshita, J.H., 1986, Aldose reductase localization in dog retinal mural cells. Current Eye Res 5: 883–886.CrossRefGoogle Scholar
  8. 8.
    Kern, T.S., Engerman, R.L., 1985, Hexitol production by canine retinal microvessels. Invest Ophthalmol Vis Sci 26: 382–384.PubMedGoogle Scholar
  9. 9.
    Hohman, T.C., Nishimura, C., Robison, W.G., Jr., 1988, Aldose reductase and polyol in cultured pericytes of human retinal capillaries. Exp Eye Res (in press).Google Scholar
  10. 10.
    Buzney, S.M., Frank, R.N., Varma, S.D., Tanishima, T. and Gabbay, K.H., 1977, Aldose reductase in retinal mural cells. Invest Ophthalmol Vis Sci 16: 392–396.PubMedGoogle Scholar
  11. 11.
    Kador, P.F., Akagi, Y., Terubayashi, H., Wyman, M., Kinoshita, J.H., 1988, Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors. Archiv Ophthalmol (in press).Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • W. Gerald RobisonJr.
    • 1
  1. 1.Section on Pathophysiology, Laboratory of Mechanisms of Ocular Diseases National Eye InstituteNational Institutes of HealthBethesdaUSA

Personalised recommendations